25 XP   0   0   10

CureVac NV
Buy, Hold or Sell?

Let's analyse Curevac together

PenkeI guess you are interested in CureVac NV. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of CureVac NV. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about CureVac NV

I send you an email if I find something interesting about CureVac NV.

Quick analysis of Curevac (30 sec.)










What can you expect buying and holding a share of Curevac? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€2.69
Expected worth in 1 year
€2.59
How sure are you?
26.7%

+ What do you gain per year?

Total Gains per Share
€-0.10
Return On Investment
-3.6%

For what price can you sell your share?

Current Price per Share
€2.79
Expected price per share
€2.53 - €3.07
How sure are you?
50%

1. Valuation of Curevac (5 min.)




Live pricePrice per Share (EOD)

€2.79

Intrinsic Value Per Share

€-115.00 - €-137.86

Total Value Per Share

€-112.31 - €-135.17

2. Growth of Curevac (5 min.)




Is Curevac growing?

Current yearPrevious yearGrowGrow %
How rich?$651.4m$706.2m-$30.7m-4.5%

How much money is Curevac making?

Current yearPrevious yearGrowGrow %
Making money-$81.7m-$33m-$48.7m-59.6%
Net Profit Margin-773.0%-194.2%--

How much money comes from the company's main activities?

3. Financial Health of Curevac (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#85 / 1031

Most Revenue
#266 / 1031

Most Profit
#991 / 1031

Most Efficient
#805 / 1031

What can you expect buying and holding a share of Curevac? (5 min.)

Welcome investor! Curevac's management wants to use your money to grow the business. In return you get a share of Curevac.

What can you expect buying and holding a share of Curevac?

First you should know what it really means to hold a share of Curevac. And how you can make/lose money.

Speculation

The Price per Share of Curevac is €2.79. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Curevac.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Curevac, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €2.69. Based on the TTM, the Book Value Change Per Share is €-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Curevac.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.24-8.4%-0.24-8.4%-0.15-5.3%-0.28-10.2%-0.28-10.2%
Usd Book Value Change Per Share-0.23-8.1%-0.03-1.0%-0.08-3.0%0.197.0%0.197.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.23-8.1%-0.03-1.0%-0.08-3.0%0.197.0%0.197.0%
Usd Price Per Share6.99-7.58-18.66-28.65-28.65-
Price to Earnings Ratio-7.43--8.06--240.06--80.22--80.22-
Price-to-Total Gains Ratio-30.92--17.51--72.60--53.37--53.37-
Price to Book Ratio2.40-2.52-5.82-8.30-8.30-
Price-to-Total Gains Ratio-30.92--17.51--72.60--53.37--53.37-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.017943
Number of shares331
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.030.19
Usd Total Gains Per Share-0.030.19
Gains per Quarter (331 shares)-9.0864.20
Gains per Year (331 shares)-36.33256.80
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-36-460257247
20-73-820514504
30-109-1180770761
40-145-154010271018
50-182-190012841275
60-218-226015411532
70-254-262017981789
80-291-298020542046
90-327-334023112303
100-363-370025682560

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.015.00.00.0%0.015.00.00.0%0.015.00.00.0%
Book Value Change Per Share1.03.00.025.0%3.08.01.025.0%4.010.01.026.7%4.010.01.026.7%4.010.01.026.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.015.00.0%0.00.015.00.0%0.00.015.00.0%
Total Gains per Share1.03.00.025.0%3.08.01.025.0%4.010.01.026.7%4.010.01.026.7%4.010.01.026.7%

Fundamentals of Curevac

About CureVac NV

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer therapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.

Fundamental data was last updated by Penke on 2024-03-27 15:14:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of CureVac NV.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Curevac earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Curevac to the Biotechnology industry mean.
  • A Net Profit Margin of -295.3% means that €-2.95 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CureVac NV:

  • The MRQ is -295.3%. The company is making a huge loss. -2
  • The TTM is -773.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-295.3%TTM-773.0%+477.7%
TTM-773.0%YOY-194.2%-578.8%
TTM-773.0%5Y-608.9%-164.1%
5Y-608.9%10Y-608.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-295.3%-171.8%-123.5%
TTM-773.0%-205.8%-567.2%
YOY-194.2%-262.1%+67.9%
5Y-608.9%-455.6%-153.3%
10Y-608.9%-589.0%-19.9%
1.1.2. Return on Assets

Shows how efficient Curevac is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Curevac to the Biotechnology industry mean.
  • -5.8% Return on Assets means that Curevac generated €-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CureVac NV:

  • The MRQ is -5.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.8%TTM-8.5%+2.8%
TTM-8.5%YOY-3.3%-5.3%
TTM-8.5%5Y-8.1%-0.4%
5Y-8.1%10Y-8.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.8%-12.5%+6.7%
TTM-8.5%-12.2%+3.7%
YOY-3.3%-11.2%+7.9%
5Y-8.1%-13.4%+5.3%
10Y-8.1%-14.7%+6.6%
1.1.3. Return on Equity

Shows how efficient Curevac is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Curevac to the Biotechnology industry mean.
  • -8.1% Return on Equity means Curevac generated €-0.08 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CureVac NV:

  • The MRQ is -8.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.1%TTM-12.7%+4.6%
TTM-12.7%YOY-4.8%-7.8%
TTM-12.7%5Y-9.2%-3.5%
5Y-9.2%10Y-9.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.1%-15.8%+7.7%
TTM-12.7%-15.7%+3.0%
YOY-4.8%-13.9%+9.1%
5Y-9.2%-18.3%+9.1%
10Y-9.2%-19.2%+10.0%

1.2. Operating Efficiency of CureVac NV.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Curevac is operating .

  • Measures how much profit Curevac makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Curevac to the Biotechnology industry mean.
  • An Operating Margin of -332.9% means the company generated €-3.33  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CureVac NV:

  • The MRQ is -332.9%. The company is operating very inefficient. -2
  • The TTM is -449.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-332.9%TTM-449.4%+116.4%
TTM-449.4%YOY-514.2%+64.8%
TTM-449.4%5Y-599.5%+150.2%
5Y-599.5%10Y-599.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-332.9%-299.1%-33.8%
TTM-449.4%-210.1%-239.3%
YOY-514.2%-279.7%-234.5%
5Y-599.5%-459.9%-139.6%
10Y-599.5%-596.9%-2.6%
1.2.2. Operating Ratio

Measures how efficient Curevac is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 5.78 means that the operating costs are €5.78 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of CureVac NV:

  • The MRQ is 5.780. The company is inefficient in keeping operating costs low. -1
  • The TTM is 12.593. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.780TTM12.593-6.813
TTM12.593YOY4.991+7.602
TTM12.5935Y9.311+3.282
5Y9.31110Y9.3110.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.7802.861+2.919
TTM12.5933.193+9.400
YOY4.9913.615+1.376
5Y9.3115.560+3.751
10Y9.3117.396+1.915

1.3. Liquidity of CureVac NV.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Curevac is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.56 means the company has €3.56 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of CureVac NV:

  • The MRQ is 3.563. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.692. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.563TTM4.692-1.129
TTM4.692YOY3.253+1.440
TTM4.6925Y3.673+1.019
5Y3.67310Y3.6730.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5633.986-0.423
TTM4.6924.440+0.252
YOY3.2535.552-2.299
5Y3.6736.158-2.485
10Y3.6736.492-2.819
1.3.2. Quick Ratio

Measures if Curevac is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Curevac to the Biotechnology industry mean.
  • A Quick Ratio of 0.17 means the company can pay off €0.17 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CureVac NV:

  • The MRQ is 0.167. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.153. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.167TTM0.153+0.014
TTM0.153YOY0.234-0.081
TTM0.1535Y0.170-0.017
5Y0.17010Y0.1700.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1673.638-3.471
TTM0.1534.168-4.015
YOY0.2345.515-5.281
5Y0.1706.012-5.842
10Y0.1706.209-6.039

1.4. Solvency of CureVac NV.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Curevac assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Curevac to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.29 means that Curevac assets are financed with 28.5% credit (debt) and the remaining percentage (100% - 28.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of CureVac NV:

  • The MRQ is 0.285. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.303. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.285TTM0.303-0.018
TTM0.303YOY0.347-0.044
TTM0.3035Y0.509-0.207
5Y0.50910Y0.5090.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2850.335-0.050
TTM0.3030.330-0.027
YOY0.3470.267+0.080
5Y0.5090.367+0.142
10Y0.5090.378+0.131
1.4.2. Debt to Equity Ratio

Measures if Curevac is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Curevac to the Biotechnology industry mean.
  • A Debt to Equity ratio of 39.9% means that company has €0.40 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CureVac NV:

  • The MRQ is 0.399. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.441. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.399TTM0.441-0.042
TTM0.441YOY0.537-0.096
TTM0.4415Y0.603-0.162
5Y0.60310Y0.6030.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3990.376+0.023
TTM0.4410.398+0.043
YOY0.5370.334+0.203
5Y0.6030.429+0.174
10Y0.6030.476+0.127

2. Market Valuation of CureVac NV

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Curevac generates.

  • Above 15 is considered overpriced but always compare Curevac to the Biotechnology industry mean.
  • A PE ratio of -7.43 means the investor is paying €-7.43 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CureVac NV:

  • The EOD is -3.208. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.429. Based on the earnings, the company is expensive. -2
  • The TTM is -8.063. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.208MRQ-7.429+4.220
MRQ-7.429TTM-8.063+0.634
TTM-8.063YOY-240.062+231.999
TTM-8.0635Y-80.216+72.153
5Y-80.21610Y-80.2160.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.208-2.643-0.565
MRQ-7.429-2.418-5.011
TTM-8.063-2.742-5.321
YOY-240.062-4.123-235.939
5Y-80.216-6.257-73.959
10Y-80.216-6.478-73.738
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CureVac NV:

  • The EOD is -2.111. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.887. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.854. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.111MRQ-4.887+2.776
MRQ-4.887TTM-4.854-0.033
TTM-4.854YOY-7.337+2.483
TTM-4.8545Y-6.088+1.233
5Y-6.08810Y-6.0880.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.111-3.244+1.133
MRQ-4.887-2.939-1.948
TTM-4.854-3.478-1.376
YOY-7.337-5.592-1.745
5Y-6.088-8.473+2.385
10Y-6.088-8.881+2.793
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Curevac is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.40 means the investor is paying €2.40 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of CureVac NV:

  • The EOD is 1.037. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.402. Based on the equity, the company is underpriced. +1
  • The TTM is 2.518. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.037MRQ2.402-1.365
MRQ2.402TTM2.518-0.116
TTM2.518YOY5.820-3.302
TTM2.5185Y8.298-5.780
5Y8.29810Y8.2980.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.0372.124-1.087
MRQ2.4022.041+0.361
TTM2.5182.118+0.400
YOY5.8202.915+2.905
5Y8.2983.682+4.616
10Y8.2984.114+4.184
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of CureVac NV compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.209-0.025-88%-0.078-62%0.179-217%0.179-217%
Book Value Per Share--2.6902.789-4%2.916-8%2.601+3%2.601+3%
Current Ratio--3.5634.692-24%3.253+10%3.673-3%3.673-3%
Debt To Asset Ratio--0.2850.303-6%0.347-18%0.509-44%0.509-44%
Debt To Equity Ratio--0.3990.441-9%0.537-26%0.603-34%0.603-34%
Dividend Per Share----0%-0%-0%-0%
Eps---0.217-0.2170%-0.136-37%-0.262+21%-0.262+21%
Free Cash Flow Per Share---0.330-0.374+13%-0.589+78%-0.209-37%-0.209-37%
Free Cash Flow To Equity Per Share---0.336-0.379+13%-0.593+76%-0.072-78%-0.072-78%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---137.856--------
Intrinsic Value_10Y_min---115.004--------
Intrinsic Value_1Y_max---3.393--------
Intrinsic Value_1Y_min---3.326--------
Intrinsic Value_3Y_max---18.136--------
Intrinsic Value_3Y_min---17.154--------
Intrinsic Value_5Y_max---42.454--------
Intrinsic Value_5Y_min---38.722--------
Market Cap624747960.000-132%1446549040.0001569987145.000-8%3863472734.000-63%5931209342.400-76%5931209342.400-76%
Net Profit Margin---2.953-7.730+162%-1.942-34%-6.089+106%-6.089+106%
Operating Margin---3.329-4.494+35%-5.142+54%-5.995+80%-5.995+80%
Operating Ratio--5.78012.593-54%4.991+16%9.311-38%9.311-38%
Pb Ratio1.037-132%2.4022.518-5%5.820-59%8.298-71%8.298-71%
Pe Ratio-3.208+57%-7.429-8.063+9%-240.062+3132%-80.216+980%-80.216+980%
Price Per Share2.790-132%6.4607.011-8%17.254-63%26.488-76%26.488-76%
Price To Free Cash Flow Ratio-2.111+57%-4.887-4.854-1%-7.337+50%-6.088+25%-6.088+25%
Price To Total Gains Ratio-13.354+57%-30.921-17.512-43%-72.603+135%-53.366+73%-53.366+73%
Quick Ratio--0.1670.153+9%0.234-28%0.170-2%0.170-2%
Return On Assets---0.058-0.085+48%-0.033-43%-0.081+41%-0.081+41%
Return On Equity---0.081-0.127+57%-0.048-40%-0.092+14%-0.092+14%
Total Gains Per Share---0.209-0.025-88%-0.078-62%0.179-217%0.179-217%
Usd Book Value--651470050.500675511914.700-4%706221377.700-8%630103590.967+3%630103590.967+3%
Usd Book Value Change Per Share---0.226-0.027-88%-0.085-62%0.194-217%0.194-217%
Usd Book Value Per Share--2.9093.017-4%3.154-8%2.814+3%2.814+3%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.235-0.2350%-0.148-37%-0.284+21%-0.284+21%
Usd Free Cash Flow---80047963.400-90544239.350+13%-142599699.725+78%-50597022.293-37%-50597022.293-37%
Usd Free Cash Flow Per Share---0.357-0.404+13%-0.637+78%-0.226-37%-0.226-37%
Usd Free Cash Flow To Equity Per Share---0.363-0.410+13%-0.641+76%-0.078-78%-0.078-78%
Usd Market Cap675789868.332-132%1564732096.5681698255094.747-8%4179118456.368-63%6415789145.674-76%6415789145.674-76%
Usd Price Per Share3.018-132%6.9887.584-8%18.663-63%28.652-76%28.652-76%
Usd Profit---52658237.700-81748936.650+55%-33040796.925-37%-71264775.740+35%-71264775.740+35%
Usd Revenue--17829661.10011595824.000+54%26219326.300-32%16059495.107+11%16059495.107+11%
Usd Total Gains Per Share---0.226-0.027-88%-0.085-62%0.194-217%0.194-217%
 EOD+3 -5MRQTTM+18 -13YOY+12 -215Y+17 -1610Y+17 -16

3.2. Fundamental Score

Let's check the fundamental score of CureVac NV based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.208
Price to Book Ratio (EOD)Between0-11.037
Net Profit Margin (MRQ)Greater than0-2.953
Operating Margin (MRQ)Greater than0-3.329
Quick Ratio (MRQ)Greater than10.167
Current Ratio (MRQ)Greater than13.563
Debt to Asset Ratio (MRQ)Less than10.285
Debt to Equity Ratio (MRQ)Less than10.399
Return on Equity (MRQ)Greater than0.15-0.081
Return on Assets (MRQ)Greater than0.05-0.058
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of CureVac NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.142
Ma 20Greater thanMa 502.970
Ma 50Greater thanMa 1003.142
Ma 100Greater thanMa 2003.845
OpenGreater thanClose2.775
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets842,566
Total Liabilities240,301
Total Stockholder Equity602,265
 As reported
Total Liabilities 240,301
Total Stockholder Equity+ 602,265
Total Assets = 842,566

Assets

Total Assets842,566
Total Current Assets536,833
Long-term Assets305,732
Total Current Assets
Cash And Cash Equivalents 464,145
Short-term Investments 3,455
Net Receivables 21,750
Inventory 23,300
Other Current Assets 13,341
Total Current Assets  (as reported)536,833
Total Current Assets  (calculated)525,991
+/- 10,842
Long-term Assets
Property Plant Equipment 272,217
Other Assets 3,047
Long-term Assets  (as reported)305,732
Long-term Assets  (calculated)275,264
+/- 30,468

Liabilities & Shareholders' Equity

Total Current Liabilities150,679
Long-term Liabilities89,622
Total Stockholder Equity602,265
Total Current Liabilities
Accounts payable 12,570
Other Current Liabilities 132,575
Total Current Liabilities  (as reported)150,679
Total Current Liabilities  (calculated)145,145
+/- 5,534
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt42,114
Other Liabilities 53,042
Long-term Liabilities  (as reported)89,622
Long-term Liabilities  (calculated)95,156
+/- 5,534
Total Stockholder Equity
Common Stock26,871
Retained Earnings -1,479,329
Other Stockholders Equity 2,054,723
Total Stockholder Equity (as reported)602,265
Total Stockholder Equity (calculated)602,265
+/-0
Other
Capital Stock26,871
Common Stock Shares Outstanding 223,883
Net Invested Capital 602,265
Net Tangible Assets 571,796
Net Working Capital 386,154
Property Plant and Equipment Gross 272,217



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-03-312019-12-312019-03-31
> Total Assets 
0
130,620
155,656
1,021,907
1,511,356
0
1,801,045
1,663,127
1,158,242
1,026,653
925,820
910,512
860,472
973,672
899,480
842,566
842,566899,480973,672860,472910,512925,8201,026,6531,158,2421,663,1271,801,04501,511,3561,021,907155,656130,6200
   > Total Current Assets 
0
57,175
60,108
915,500
1,389,854
1,608,942
1,608,942
1,454,094
940,019
789,289
675,589
622,282
584,029
686,916
603,210
536,833
536,833603,210686,916584,029622,282675,589789,289940,0191,454,0941,608,9421,608,9421,389,854915,50060,10857,1750
       Cash And Cash Equivalents 
0
30,684
43,474
892,399
1,322,593
0
1,355,812
1,060,971
811,464
658,203
573,566
540,865
495,797
617,519
537,925
464,145
464,145537,925617,519495,797540,865573,566658,203811,4641,060,9711,355,81201,322,593892,39943,47430,6840
       Short-term Investments 
0
1,458
1,418
1,129
2,619
0
40,107
7,712
4,648
4,664
3,608
2,599
4,487
3,069
5,354
3,455
3,4555,3543,0694,4872,5993,6084,6644,6487,71240,10702,6191,1291,4181,4580
       Net Receivables 
0
17,686
4,832
535
12,246
4,894
4,894
2,452
56,450
28,025
74,302
36,857
41,988
3,379
6,443
21,750
21,7506,4433,37941,98836,85774,30228,02556,4502,4524,8944,89412,2465354,83217,6860
       Other Current Assets 
0
533
0
0
430
0
40,107
0
10,222
4,664
9,827
14,693
12,403
25,597
11,878
13,341
13,34111,87825,59712,40314,6939,8274,66410,222040,1070430005330
   > Long-term Assets 
0
73,445
95,548
106,407
121,502
0
192,103
209,033
218,223
237,364
250,231
288,230
276,443
286,756
296,270
305,732
305,732296,270286,756276,443288,230250,231237,364218,223209,033192,1030121,502106,40795,54873,4450
       Property Plant Equipment 
0
61,686
87,232
94,057
100,589
168,104
168,104
0
200,393
221,311
235,011
251,461
241,702
253,163
261,570
272,217
272,217261,570253,163241,702251,461235,011221,311200,3930168,104168,104100,58994,05787,23261,6860
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
12,463
0
0
0
00012,463000000000000
       Intangible Assets 
0
5,698
6,120
10,138
14,146
0
16,196
13,572
13,238
0
0
0
19,315
0
0
0
00019,31500013,23813,57216,196014,14610,1386,1205,6980
       Other Assets 
0
6,343
2,196
2,212
7,455
7,803
7,803
0
5,557
3,417
2,939
2,994
2,974
0
0
3,047
3,047002,9742,9942,9393,4175,55707,8037,8037,4552,2122,1966,3430
> Total Liabilities 
0
173,422
199,313
260,557
800,009
0
965,727
967,833
469,766
351,795
302,618
285,524
327,219
260,273
250,433
240,301
240,301250,433260,273327,219285,524302,618351,795469,766967,833965,7270800,009260,557199,313173,4220
   > Total Current Liabilities 
0
28,086
36,493
110,525
247,622
814,001
814,001
814,056
357,734
237,835
195,633
172,352
156,225
90,298
156,276
150,679
150,679156,27690,298156,225172,352195,633237,835357,734814,056814,001814,001247,622110,52536,49328,0860
       Accounts payable 
0
5,331
6,078
50,225
17,623
76,569
76,569
60,280
122,263
63,407
48,496
52,608
68,245
14,973
13,419
12,570
12,57013,41914,97368,24552,60848,49663,407122,26360,28076,56976,56917,62350,2256,0785,3310
       Other Current Liabilities 
0
16,379
27,327
57,379
207,578
734,289
734,289
103,890
222,647
170,319
142,859
115,092
72,954
37,715
35,514
132,575
132,57535,51437,71572,954115,092142,859170,319222,647103,890734,289734,289207,57857,37927,32716,3790
   > Long-term Liabilities 
0
145,336
162,820
150,032
552,387
0
151,726
153,777
112,032
113,960
106,985
113,172
170,994
169,975
94,157
89,622
89,62294,157169,975170,994113,172106,985113,960112,032153,777151,7260552,387150,032162,820145,3360
       Other Liabilities 
0
68,192
66,422
122,308
500,345
99,175
99,175
0
86,609
77,410
71,054
76,563
0
0
0
53,042
53,04200076,56371,05477,41086,609099,17599,175500,345122,30866,42268,1920
       Deferred Long Term Liability 
0
966
0
0
1,034
0
0
0
515
0
0
0
302
0
0
0
0003020005150001,034009660
> Total Stockholder Equity
0
-42,802
-43,657
761,350
711,347
0
835,318
695,294
688,476
674,858
623,202
624,988
533,253
713,399
649,047
602,265
602,265649,047713,399533,253624,988623,202674,858688,476695,294835,3180711,347761,350-43,657-42,8020
   Common Stock
0
11,603
743
21,560
21,655
22,425
22,425
0
22,454
22,454
22,496
22,834
0
0
0
26,871
26,87100022,83422,49622,45422,454022,42522,42521,65521,56074311,6030
   Retained Earnings Total Equity0000000000000000
   Accumulated Other Comprehensive Income 0000000000000000
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
461,542
495,397
1,326,712
1,334,761
1,726,740
1,726,740
0
1,728,624
1,727,378
1,731,902
1,780,918
0
0
0
2,054,723
2,054,7230001,780,9181,731,9021,727,3781,728,62401,726,7401,726,7401,334,7611,326,712495,397461,5420



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue42,880
Cost of Revenue-150,770
Gross Profit-107,890-107,890
 
Operating Income (+$)
Gross Profit-107,890
Operating Expense-352,018
Operating Income-309,138-459,908
 
Operating Expense (+$)
Research Development109,979
Selling General Administrative78,418
Selling And Marketing Expenses-
Operating Expense352,018188,397
 
Net Interest Income (+$)
Interest Income12,921
Interest Expense-7,449
Other Finance Cost-0
Net Interest Income5,472
 
Pretax Income (+$)
Operating Income-309,138
Net Interest Income5,472
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-302,231-310,574
EBIT - interestExpense = -7,449
-302,298
-294,849
Interest Expense7,449
Earnings Before Interest and Taxes (EBIT)--294,782
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-302,231
Tax Provision-67
Net Income From Continuing Ops-302,298-302,298
Net Income-302,298
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net1,436-5,472
 

Technical Analysis of Curevac
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Curevac. The general trend of Curevac is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Curevac's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of CureVac NV.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3 < 3 < 3.07.

The bearish price targets are: 2.53.

Tweet this
CureVac NV Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of CureVac NV. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

CureVac NV Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of CureVac NV. The current macd is -0.12466973.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Curevac price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Curevac. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Curevac price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
CureVac NV Daily Moving Average Convergence/Divergence (MACD) ChartCureVac NV Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of CureVac NV. The current adx is 28.78.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Curevac shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
CureVac NV Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of CureVac NV. The current sar is 2.556368.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
CureVac NV Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of CureVac NV. The current rsi is 39.14. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
CureVac NV Daily Relative Strength Index (RSI) ChartCureVac NV Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of CureVac NV. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Curevac price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
CureVac NV Daily Stochastic Oscillator ChartCureVac NV Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of CureVac NV. The current cci is -103.30912026.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
CureVac NV Daily Commodity Channel Index (CCI) ChartCureVac NV Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of CureVac NV. The current cmo is -20.88155976.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
CureVac NV Daily Chande Momentum Oscillator (CMO) ChartCureVac NV Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of CureVac NV. The current willr is -63.88888889.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Curevac is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
CureVac NV Daily Williams %R ChartCureVac NV Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of CureVac NV.

CureVac NV Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of CureVac NV. The current atr is 0.15806638.

CureVac NV Daily Average True Range (ATR) ChartCureVac NV Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of CureVac NV. The current obv is -561,413.

CureVac NV Daily On-Balance Volume (OBV) ChartCureVac NV Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of CureVac NV. The current mfi is 28.88.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
CureVac NV Daily Money Flow Index (MFI) ChartCureVac NV Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for CureVac NV.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-21 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-22 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-23 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-30 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-22 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-23 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-13 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-19 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-21 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-22 00:00:00MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-25 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

CureVac NV Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of CureVac NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.142
Ma 20Greater thanMa 502.970
Ma 50Greater thanMa 1003.142
Ma 100Greater thanMa 2003.845
OpenGreater thanClose2.775
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Curevac with someone you think should read this too:
  • Are you bullish or bearish on Curevac? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Curevac? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about CureVac NV

I send you an email if I find something interesting about CureVac NV.


Comments

How you think about this?

Leave a comment

Stay informed about CureVac NV.

Receive notifications about CureVac NV in your mailbox!